In search of a window of opportunity in axial spondyloarthritis: treatment outcomes across different symptom durations
Objectives: This study aimed to determine the effectiveness of a first tumour necrosis factor inhibitor (TNFi) in patients with short and long symptom duration in axial spondyloarthritis (axSpA), using alternative cut-offs for back pain duration: ≤1 year as very early, >1 year, and ≤5 years as inter...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Elsevier
2026-06-01
|
| Цуврал: | EULAR Rheumatology Open |
| Онлайн хандалт: | http://www.sciencedirect.com/science/article/pii/S3050708126000728 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
